Pfizer and Astellas seek updated EMA approval for Padcev with Keytruda

Retrieved on: 2024-01-29 16:46:26

Tags for this article:

Antineoplastic drugs

Orphan drugs

Cancer immunotherapy

Pembrolizumab

Seagen

Antibody-drug conjugate

Astellas Pharma

Transitional cell carcinoma

Click the tags to see associated articles and topics

Pfizer and Astellas seek updated EMA approval for Padcev with Keytruda. View article details on HISWAI: https://www.pharmaceutical-technology.com/news/pfizer-and-astellas-seek-updated-ema-approval-for-padcev-with-keytruda/

Excerpt

Pfizer and Astellas Pharma could soon see their leading antibody-drug conjugate Padcev (enfortumab vedotin) find wider use in early settings as a ...

Article found on: www.pharmaceutical-technology.com

View Original Article